Dr. Brigham Hyde is CEO and co-founder of Atropos Health since August 2022. Hyde has a significant track record of building businesses in the health tech and real-world data (RWD) space and most recently served as President of Data & Analytics at Eversana. Before that role, Mr. Hyde served as a healthcare partner at the AI venture fund Symphony AI, where he led the investment in, co-founded, and operated Concert AI, an oncology RWD company – most recently valued at $1.9B. Hyde held previous roles as Chief Data Officer at Decision Resources Group, which was acquired by Clarivate for $900M in 2020. He has also served on the Global Data Science Advisory Board for Janssen, as a research faculty member at MIT Media Lab, and as an adjunct faculty member at Tufts Medical School.
With evidence generated in minutes, the days of broad-based guidelines will be gone, as researchers and clinicians will have personalized evidence at their fingertips that can transform value-based care.